Back to Anual Masterclass AGM

AGM 2017 Agenda

Friday, 7th July

15:00-15:15

Welcome and introductions

  • Hans Scheurer, President of MPE
  • Ananda Plate, CEO of MPE
15:15-15:45

Driving through the conference

  • Hans Scheurer, President of MPE
  • Alfonso Aguarón, Project Manager of MPE
15:45-17:00

MPE dialogues:

“Where are we now in myeloma and how does the future look like?”

  • Dr. Albert Oriol, Hematology Department, Institut Català d’Oncologia, Spain
  • Sofia Sá Cardoso, Director of Portuguese Association Against Leukaemia (APCL)
  • Susanna Leto, former Patient Advocacy Director of Novartis Oncology Europe
  • Jaime Espín, PhD Professor in the Andalusian School of Public Health
  • Dr Beatriz Flores, Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency (MHRA), UK
17:00-17:15 Coffee break
17:15-18:30

Atlas update

  • Ananda Plate, CEO of MPE
  • Kristina Modic, Director of L&L Slovenia
  • Lucica Nitu, President of SOS Mielom Romania
19:00-20:30 Dinner

Saturday, 8th July

09:00 – 10:00

Update on current diagnosis and treatment of myeloma and related diseases

  • Dr. Sonja Zweegman, VU University Medical Center of Amsterdam, Netherlands
10:00-10:15 Coffee break
10:15-11:15 BREAKOUT SESSIONS

AL amyloidosis

  • Dr. Giampaolo Merlini, Scientific Institute Policlinico San Matteo, University of Pavia, Italy

Stem cell transplant in myeloma

  • Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
11:15 – 11:30 Coffee break
11:30 – 12:30 BREAKOUT SESSION
Clinical trials and drugs under development
in myeloma & AL amyloidosis
  • Dr. Laurent Garderet, Saint-Antoine Hospital
    of Paris, France

Panel on myeloma treatment in the light of access barriers

  • Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
12:30 – 14:00 Lunch
14:00 – 16:15

ROTATING SESSIONS (45 minutes each – Choose 3 out of 4)

Cross Border Healthcare

  • Ananda Plate, CEO of Myeloma Patients Europe

Psychosocial -best practices in supporting patients and carers through the patient journey

  • Ibolya Keri, President of the Foundation for Hungarian Onco-haematological Patients

Drug approval route

  • Kate Morgan, Policy and Public Affairs Manager at Myeloma UK

Engaging with industry

  • Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group
16:15 – 16:45 Coffee break
16:45 – 17:45

Patient advocate development strategies. How can an umbrella organisation help you? ·

MPE Advocate Development Programme update

  • Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group
  • Ananda Plate, CEO of MPE
  • Lucica Nitu, President of SOS Mielom Romania
19:00 – 21:00 Off-site dinner

Sunday, 9th July

9:00 – 13:00 Annual General Meeting (Agenda to be defined)
13:00 – 14:00 Farewell lunch

What we do

Back to Anual Masterclass AGM

AGM 2017 Agenda

Friday, 7th July

15:00-15:15

Welcome and introductions

  • Hans Scheurer, President of MPE
  • Ananda Plate, CEO of MPE
15:15-15:45

Driving through the conference

  • Hans Scheurer, President of MPE
  • Alfonso Aguarón, Project Manager of MPE
15:45-17:00

MPE dialogues:

“Where are we now in myeloma and how does the future look like?”

  • Dr. Albert Oriol, Hematology Department, Institut Català d’Oncologia, Spain
  • Sofia Sá Cardoso, Director of Portuguese Association Against Leukaemia (APCL)
  • Susanna Leto, former Patient Advocacy Director of Novartis Oncology Europe
  • Jaime Espín, PhD Professor in the Andalusian School of Public Health
  • Dr Beatriz Flores, Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency (MHRA), UK
17:00-17:15 Coffee break
17:15-18:30

Atlas update

  • Ananda Plate, CEO of MPE
  • Kristina Modic, Director of L&L Slovenia
  • Lucica Nitu, President of SOS Mielom Romania
19:00-20:30 Dinner

Saturday, 8th July

09:00-10:00

Update on current diagnosis and treatment of myeloma and related diseases

  • Dr. Sonja Zweegman, VU University Medical Center of Amsterdam, Netherlands
10:00-10:15 Coffee break
10:15-11:15 BREAKOUT SESSIONS

AL amyloidosis

  • Dr. Giampaolo Merlini, Scientific Institute Policlinico San Matteo, University of Pavia, Italy

Stem cell transplant in myeloma

  • Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
11:15 – 11:30 Coffee break
11:30 – 12:30 BREAKOUT SESSION
Clinical trials and drugs under development
in myeloma & AL amyloidosis
  • Dr. Laurent Garderet, Saint-Antoine Hospital
    of Paris, France

Panel on myeloma treatment in the light of access barriers

  • Dr. Gabor Mikala, St. Laszlo Hospital, Budapest, Hungary
12:30 – 14:00 Lunch
14:00 – 16:15

ROTATING SESSIONS (45 minutes each – Choose 3 out of 4)

Cross Border Healthcare

  • Ananda Plate, CEO of Myeloma Patients Europe

Psychosocial -best practices in supporting patients and carers through the patient journey

  • Ibolya Keri, President of the Foundation for Hungarian Onco-haematological Patients

Drug approval route

  • Kate Morgan, Policy and Public Affairs Manager at Myeloma UK

Engaging with industry

  • Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group
16:15 – 16:45 Coffee break
16:45 – 17:45

Patient advocate development strategies. How can an umbrella organisation help you? ·

MPE Advocate Development Programme update

  • Tamás Bereczky, Communications Advisor of the European AIDS Treatment Group
  • Ananda Plate, CEO of MPE
  • Lucica Nitu, President of SOS Mielom Romania
19:00 – 21:00 Off-site dinner

Sunday, 9th July

09:00–13:00 Annual General Meeting (Agenda to be defined)
13:00–14:00 Farewell lunch

Subscribe to

our newsletter!

Subscribe here